Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
3.590
-0.130 (-3.49%)
Jun 20, 2025, 12:56 PM - Market open
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $38.65 million as of June 20, 2025. Its market cap has decreased by -53.20% in one year.
Market Cap
38.65M
Enterprise Value
-23.91M
1-Year Change
-53.20%
Ranking
Category
Stock Price
$3.59
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $38.65M, a decrease of -98.46%. That is a compound annual growth rate of -56.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 40.05M | -42.16% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | 2.40B | -4.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 331.06B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |